Human Longevity Stock
Human Longevity is on a mission to discover and harness the technological and biological unlocks that amplify span of life, health, and high-performance. HLI’s mission is to identify the therapeutically targetable mechanisms responsible for age-related human biological decline and to apply this intelligence to develop innovative solutions to interrupt or block those processes, meaningfully extending the human lifespan.
Sign up today for more details and to buy or sell Human Longevity Stock
Buy + SellSee Valuations and Financials
Gain insights Into Human Longevity Stock Valuation + Share Prices
Get started to view real-time data on Human Longevity stock including most recent valuation and historical share price information.
Get StartedHuman Longevity Management Team
President, Chief Innovation Officer
David Karow
Director
Brett Blundy
Director
Wei-Wu He
Co-Founder, Director
Peter Diamandis
Chief Privacy Officer
Mert Gambito
Director
Alan B. Colowick
Director
Robert Duggan
Director
Robert Hariri
Director
Maky Zanganeh
Director
KT Lim
Chief Medical Officer
Julie Chen
Medical Director, Health Nucleus
Pamila Brar
Co-Founder
J. Craig Venter
Human Longevity Major Investors
Faridan Ventures
Illumina
GE Ventures (General Electric Company)
BB Retail Capital
Draper Fisher Jurvetson
Emerging Technology Partners LLC
Celgene Corp
Genting Berhad
OS Fund
TVM Capital Healthcare
Panacea Venture
Emerging Technology Partners